Eric K. Nicholson

Array ( [id] => 5936066 [patent_doc_number] => 20110212160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'CONFIGURABLE MICROSCOPIC MEDICAL PAYLOAD DELIVERY DEVICE TO DELIVER NUCLEAR SIGNALING PROTEINS TO SPECIFIC CELLS TO MANAGE DIABETES MELLITUS AND GENETIC DEFICIENCY DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/715377 [patent_app_country] => US [patent_app_date] => 2010-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12086 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212160.pdf [firstpage_image] =>[orig_patent_app_number] => 12715377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5936108 [patent_doc_number] => 20110212177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'CONFIGURABLE MICROSCOPIC MEDICAL PAYLOAD DELIVERY DEVICE TO DELIVER MEDICALLY THERAPEUTIC PAYLOADS TO SPECIFICALLY TARGETED CELL TYPES' [patent_app_type] => utility [patent_app_number] => 12/715362 [patent_app_country] => US [patent_app_date] => 2010-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7643 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212177.pdf [firstpage_image] =>[orig_patent_app_number] => 12715362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6102188 [patent_doc_number] => 20110165681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'Light-Activated Proton Pumps and Applications Thereof' [patent_app_type] => utility [patent_app_number] => 12/714436 [patent_app_country] => US [patent_app_date] => 2010-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 18211 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20110165681.pdf [firstpage_image] =>[orig_patent_app_number] => 12714436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6024237 [patent_doc_number] => 20110052563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'GONADAL FUNCTION IMPROVING AGENTS' [patent_app_type] => utility [patent_app_number] => 12/710864 [patent_app_country] => US [patent_app_date] => 2010-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 36508 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052563.pdf [firstpage_image] =>[orig_patent_app_number] => 12710864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6430957 [patent_doc_number] => 20100143356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'THERAPEUTIC AND DIAGNOSTIC ANTI-HSP70 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/707502 [patent_app_country] => US [patent_app_date] => 2010-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15466 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143356.pdf [firstpage_image] =>[orig_patent_app_number] => 12707502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7579679 [patent_doc_number] => 20110293562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'USE OF CARDIOTROPHIN-1 FOR THE TREATMENT OF METABOLIC DISEASES' [patent_app_type] => utility [patent_app_number] => 13/201431 [patent_app_country] => US [patent_app_date] => 2010-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 13144 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20110293562.pdf [firstpage_image] =>[orig_patent_app_number] => 13201431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4431674 [patent_doc_number] => 07968315 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-28 [patent_title] => 'Production and purification of IL-29' [patent_app_type] => utility [patent_app_number] => 12/701358 [patent_app_country] => US [patent_app_date] => 2010-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36774 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/968/07968315.pdf [firstpage_image] =>[orig_patent_app_number] => 12701358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10026100 [patent_doc_number] => 09067989 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-30 [patent_title] => 'Eotaxin-2 (CCL24) inhibitors in inflammatory, autoimmune, and cardiovascular disorders' [patent_app_type] => utility [patent_app_number] => 13/146711 [patent_app_country] => US [patent_app_date] => 2010-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 47 [patent_no_of_words] => 12246 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13146711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6574830 [patent_doc_number] => 20100129374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'Mammalian Cell Membrane Proteins; Related Reagents' [patent_app_type] => utility [patent_app_number] => 12/693313 [patent_app_country] => US [patent_app_date] => 2010-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31180 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20100129374.pdf [firstpage_image] =>[orig_patent_app_number] => 12693313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6499273 [patent_doc_number] => 20100209929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'MULTIPLE MECHANISMS FOR MODULATION OF JAK/STAT ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/687873 [patent_app_country] => US [patent_app_date] => 2010-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 32242 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20100209929.pdf [firstpage_image] =>[orig_patent_app_number] => 12687873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6581147 [patent_doc_number] => 20100129826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'Double stranded RNA receptor (dsRNA-R) and methods relating thereto' [patent_app_type] => utility [patent_app_number] => 12/657157 [patent_app_country] => US [patent_app_date] => 2010-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5668 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20100129826.pdf [firstpage_image] =>[orig_patent_app_number] => 12657157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6631753 [patent_doc_number] => 20100173313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'BIOMARKERS OF INFLAMMATION' [patent_app_type] => utility [patent_app_number] => 12/684450 [patent_app_country] => US [patent_app_date] => 2010-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22731 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173313.pdf [firstpage_image] =>[orig_patent_app_number] => 12684450 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6002847 [patent_doc_number] => 20110118193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'TREATMENT OF LIQUID CANCERS' [patent_app_type] => utility [patent_app_number] => 12/646921 [patent_app_country] => US [patent_app_date] => 2009-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17712 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20110118193.pdf [firstpage_image] =>[orig_patent_app_number] => 12646921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9074117 [patent_doc_number] => 08551693 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-08 [patent_title] => 'Mutated voltage-gated sodium channel Nav alpha subunit for identification of modulators' [patent_app_type] => utility [patent_app_number] => 13/140657 [patent_app_country] => US [patent_app_date] => 2009-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 12582 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13140657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7650859 [patent_doc_number] => 20110300128 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'USE OF FOXP2 AS A MARKER FOR ABNORMAL LYMPHOCYTES AND AS A TARGET FOR THERAPY OF DISORDERS ASSOCIATED WITH ABNORMAL LYMPHOCYTES' [patent_app_type] => utility [patent_app_number] => 13/139028 [patent_app_country] => US [patent_app_date] => 2009-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 105 [patent_figures_cnt] => 105 [patent_no_of_words] => 24277 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20110300128.pdf [firstpage_image] =>[orig_patent_app_number] => 13139028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685103 [patent_doc_number] => 20100121038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'Template-directed assembly of receptor signaling complexes' [patent_app_type] => utility [patent_app_number] => 12/653507 [patent_app_country] => US [patent_app_date] => 2009-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12699 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20100121038.pdf [firstpage_image] =>[orig_patent_app_number] => 12653507 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7484345 [patent_doc_number] => 20110250170 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'Immunocytokines for Tumour Therapy with Chemotherapeutic Agents' [patent_app_type] => utility [patent_app_number] => 13/139655 [patent_app_country] => US [patent_app_date] => 2009-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11937 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 33 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20110250170.pdf [firstpage_image] =>[orig_patent_app_number] => 13139655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6632675 [patent_doc_number] => 20100173383 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'Nuclear Factor Of Activated T Cells Receptor' [patent_app_type] => utility [patent_app_number] => 12/636541 [patent_app_country] => US [patent_app_date] => 2009-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13228 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173383.pdf [firstpage_image] =>[orig_patent_app_number] => 12636541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7730114 [patent_doc_number] => 08101715 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-24 [patent_title] => 'Ryanodine receptor polypeptides' [patent_app_type] => utility [patent_app_number] => 12/635859 [patent_app_country] => US [patent_app_date] => 2009-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 21878 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/101/08101715.pdf [firstpage_image] =>[orig_patent_app_number] => 12635859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7730114 [patent_doc_number] => 08101715 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-24 [patent_title] => 'Ryanodine receptor polypeptides' [patent_app_type] => utility [patent_app_number] => 12/635859 [patent_app_country] => US [patent_app_date] => 2009-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 21878 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/101/08101715.pdf [firstpage_image] =>[orig_patent_app_number] => 12635859 [rel_patent_id] =>[rel_patent_doc_number] =>)